vaccin
predominantli
use
prevent
mean
establish
protect
immun
peopl
anim
protect
possibl
infect
subsequ
ill
come
contact
respect
pathogen
fundament
two
kind
immun
activ
passiv
latter
base
administr
immunoglobulin
prepar
neutral
specif
viru
therefor
passiv
vaccin
appli
special
case
person
protect
recent
verifi
contact
specif
viru
postexposur
prophylaxi
risk
exposur
pathogen
rule
follow
week
activ
vaccin
possibl
shortterm
plan
trip
third
world
countri
exposur
prophylaxi
exampl
administr
antibodi
specif
hepat
b
viru
case
contamin
blood
peopl
acut
chronic
persist
infect
viru
thu
high
concentr
infecti
particl
blood
accid
occur
primarili
medic
personnel
needlestick
injuri
sect
certain
case
administr
perform
combin
activ
vaccin
activepass
immun
specif
immunoglobulin
prepar
also
administ
peopl
bitten
anim
may
infect
rabi
viru
sect
case
earli
applic
togeth
activ
vaccin
antibodi
neutral
viru
imped
spread
bodi
sinc
time
contact
viru
spread
organ
often
short
passiv
immun
limit
period
shortli
exposur
infect
agent
usual
within
day
therefor
reserv
case
contact
potenti
pathogen
well
document
type
infect
known
appropri
immunoglobulin
prepar
avail
protect
afford
antibodi
prepar
last
week
immunoglobulin
rapidli
degrad
organ
therefor
postexposur
administr
activ
vaccin
increasingli
prefer
eg
context
outbreakcontrol
vaccin
veterinari
medicin
passiv
immun
employ
occasion
young
anim
born
flock
high
infect
pressur
approach
appli
exampl
kennel
infect
occur
canin
parvoviru
sect
howev
valu
controversi
immunoglobulin
administ
hinder
advantag
activ
immun
hand
activ
vaccin
produc
longlast
protect
infect
even
last
life
case
protect
immun
respons
induc
ideal
consist
combin
neutral
antibodi
cytotox
cell
chap
activ
immun
done
two
way
live
vaccin
use
inactiv
vaccin
variou
method
use
develop
vaccin
attempt
illustr
schemat
fig
live
vaccin
contain
attenu
replicationcompet
pathogen
replic
vaccin
person
ie
abl
infect
certain
cell
initi
synthesi
viral
protein
particl
without
trigger
respect
clinic
pictur
viral
compon
recogn
immun
system
vaccine
foreign
exogen
induc
product
specif
neutral
antibodi
cytotox
lymphocyt
chap
neutral
antibodi
predominantli
direct
viral
surfac
structur
bind
surfac
viru
thu
prevent
attach
viru
target
cell
infect
immun
complex
antibodi
viru
particl
activ
complement
system
phagocytos
macrophag
neutrophil
cytotox
cell
recogn
infect
cell
tcell
receptor
surfac
infect
cell
synthes
viral
foreign
protein
present
peptid
fragment
deriv
complex
mhc
class
antigen
recognit
lead
destruct
infect
cell
thu
elimin
viru
organ
live
vaccin
develop
effect
protect
number
viral
pathogen
effect
activ
humor
cellular
mechan
immun
system
therefor
live
vaccin
gener
ideal
vaccin
candid
howev
implement
applic
requir
refriger
system
storag
lead
difficulti
develop
countri
attenu
virus
similar
pathogen
virus
respect
structur
protein
composit
infect
behaviour
howev
clearli
differ
regard
virul
chap
comparison
wildtyp
viru
usual
caus
limit
weaken
infect
case
caus
clinic
symptom
easili
control
immun
respons
organ
protein
produc
infect
ideal
ident
virul
viru
strain
least
similar
fact
viral
polypeptid
synthes
cell
attenu
infect
lead
emerg
viru
particl
induc
gener
neutral
antibodi
cytotox
cell
therefor
immun
respons
trigger
attenu
virus
suitabl
induc
longlast
effect
protect
infect
respect
pathogen
molecular
base
attenu
mutat
genom
wildtyp
virus
differ
gene
may
affect
variou
vaccin
virus
frequent
even
known
gener
attenu
wild
type
one
way
attenu
viru
strain
continu
cultiv
passag
cell
cultur
way
viru
mutant
select
optim
adapt
cell
cultur
condit
occasion
lose
virul
process
method
made
possibl
exampl
isol
attenu
polio
measl
yellow
fever
virus
caus
diseas
human
contrast
wildtyp
infect
tabl
sect
anoth
exampl
vaccin
success
appli
protect
pig
infect
classic
swine
fever
viru
sect
case
virul
viru
attenu
continu
passag
rabbit
cell
subsequ
lapin
virus
longer
abl
trigger
diseas
swine
meanwhil
applic
origin
success
vaccin
ban
justif
lie
particularli
trade
one
hand
infect
attenu
vaccin
viru
could
distinguish
infect
classic
swine
fever
viru
blood
test
hand
follow
vaccin
export
ban
impos
limit
period
howev
econom
advers
effect
instead
attempt
interrupt
infect
chain
elimin
viru
popul
cull
herd
classic
swine
fever
occur
chap
sect
transgress
speci
barrier
infect
occasion
adopt
weaken
charact
similarli
vaccinia
virus
origin
use
produc
protect
immun
respons
smallpox
viru
induc
local
infect
human
rare
case
gener
fatal
cours
problem
attenu
vaccinia
viru
sought
repeat
passag
chicken
cell
fact
approach
result
modifi
vaccinia
ankara
viru
sect
exhibit
fewer
advers
side
effect
current
test
vector
system
express
recombin
vaccin
use
exampl
human
immunodefici
viru
hiv
patient
context
therapeut
vaccin
vaccin
attenu
live
virus
usual
confer
good
protect
remain
long
time
booster
vaccin
rel
long
interv
year
provid
continu
protect
howev
attenu
virus
entail
risk
lose
reproduct
capabl
thu
effici
inadequ
refriger
system
mutat
back
wild
type
weaken
infect
therefor
attent
paid
fact
attenu
base
multipl
independ
mutat
larg
exclud
back
mutat
pathogen
wild
type
howev
attenu
vaccin
virus
use
immunolog
healthi
peopl
immunocompromis
individu
type
virus
persist
long
time
result
symptomat
infect
sinc
attenu
live
vaccin
virus
sometim
transmit
vaccine
peopl
immedi
environ
eg
polio
vaccin
sect
restrict
also
appli
immunosuppress
peopl
famili
surround
furthermor
live
vaccin
use
pregnanc
also
import
emphas
attenu
defin
affect
host
speci
test
applic
live
vaccin
speci
evalu
occur
permit
consid
vaccin
zoo
wild
anim
unquest
use
live
vaccin
avoid
far
possibl
particular
use
live
vaccin
prohibit
infect
pathogen
wild
type
absent
occur
rare
popul
statu
achiev
success
vaccin
programm
eg
worldwid
smallpox
viru
europ
north
america
polioviru
case
risk
associ
vaccin
greater
infect
wildtyp
viru
becom
ill
therefor
case
smallpox
viru
vaccin
stop
protect
polioviru
inactiv
vaccin
use
today
sect
everi
activ
vaccin
entail
certain
rate
known
harmless
side
effect
howev
real
complic
perman
nerv
damag
rare
event
occur
preval
approxim
one
million
vaccin
adult
therefor
everi
vaccin
must
accompani
correspond
obligatori
medic
inform
document
today
recombin
virus
repres
controversi
discuss
variant
live
vaccin
attempt
modifi
wellexplor
less
pathogen
virus
eg
adenovirus
vaccin
virus
use
success
past
usual
vaccinia
virus
use
genet
engin
method
way
encod
protein
viral
speci
addit
gene
product
necessari
infect
replic
sect
viral
inocul
foreign
gene
express
recombin
virus
along
gene
organ
infect
induc
immun
respons
vaccinia
viru
adenoviru
protein
heterolog
polypeptid
recombin
replicationcompet
virus
offer
advantag
live
vaccin
antibodi
cellmedi
immun
respons
therefor
also
increasingli
use
therapeut
immun
ie
case
infect
alreadi
occur
vaccin
stimul
immun
respons
influenc
progress
diseas
favour
larg
dna
fragment
clone
genom
vaccinia
viru
despit
size
therefor
essenti
know
exactli
protein
viru
import
elicit
protect
immun
respons
order
produc
vaccin
viral
infect
pertin
gene
clone
genom
vaccinia
viru
way
control
earli
vaccinia
viru
specif
promot
vaccin
gener
entir
spectrum
immun
respons
aris
infect
wildtyp
viru
attenu
variant
recombin
vaccin
virus
immun
respons
confin
specif
protein
vaccin
extens
employ
north
america
usa
canada
europ
belgium
franc
spain
protect
raccoon
fox
rabi
genom
recombin
vaccinia
viru
harbour
genet
inform
code
g
protein
rabi
viru
sect
use
recombin
virus
meatbas
artifici
bait
prepar
scatter
fox
anim
bite
viruscontain
plastic
capsul
devour
bait
wherebi
becom
infect
vaccin
viru
develop
immun
protect
rabi
viru
infect
vaccin
base
recombin
vaccinia
virus
adenovirus
approv
human
use
yet
discuss
prevent
treatment
infect
hiv
test
experiment
accord
definit
inactiv
vaccin
abl
prolifer
vaccin
organ
induc
predominantli
antibodi
respons
lack
activ
viral
protein
synthesi
cytotox
tcell
respons
occur
rare
inactiv
vaccin
use
initi
immun
two
three
vaccin
booster
vaccin
necessari
maintain
immun
protect
enhanc
immun
respons
vaccin
appli
adjuv
facilit
migrat
macrophag
monocyt
b
lymphocyt
inocul
site
aluminium
hydroxid
aluminium
hydroxyphosph
sulphat
combin
deacyl
monophosphoryl
lipid
compon
certain
toxoid
eg
tetanu
toxoid
adjuv
approv
use
human
adjuv
also
use
anim
wide
use
adjuv
quila
saponin
also
use
product
immunestimul
complex
howev
fibrosarcoma
recent
observ
inject
site
applic
inactiv
vaccin
rabi
viru
felin
leukaemia
viru
cat
whether
elicit
adjuv
trauma
inject
conclus
elucid
experiment
immun
incomplet
freund
adjuv
use
anim
simplest
form
inactiv
vaccin
prepar
wildtyp
virus
effect
kill
treatment
chemic
inactiv
usual
done
aldehyd
alcohol
agent
frequent
bpropiolacton
also
use
protein
compon
must
denatur
extent
lose
nativ
configur
longer
similar
genuin
viral
structur
sinc
viral
nucleic
acid
per
se
frequent
infecti
lead
product
progeni
virus
method
must
use
elimin
infect
result
degrad
nucleic
acid
viru
exampl
current
commonli
use
vaccin
influenza
viru
hepat
viru
infect
tabl
base
inactiv
pathogen
rel
new
vaccin
base
sole
select
protein
compon
viru
fundament
prerequisit
develop
vaccin
detail
knowledg
immunolog
import
compon
pathogen
known
viral
protein
usual
surfac
protein
protect
immun
respons
induc
respect
code
gene
clone
eukaryot
express
system
vector
protein
synthes
purifi
final
administ
adjuv
structur
particl
protein
especi
suitabl
induct
protect
immun
respons
exampl
hbsag
surfac
protein
hepat
b
viru
aggreg
vesicular
particl
artifici
express
yeast
eukaryot
cell
hbsag
particl
induc
larg
independ
adjuv
product
hepat
b
viru
neutral
antibodi
even
cytotox
cell
sect
similarli
capsid
protein
papillomavirus
assembl
togeth
particl
resembl
infecti
virus
newli
approv
vaccin
infect
oncogen
human
papillomavirus
human
papillomavirus
base
viruslik
particl
like
aforement
hbsag
particl
produc
yeast
cell
use
genet
engin
method
sect
particleform
gag
protein
hiv
also
seem
appropri
immun
anoth
variant
type
subunit
vaccin
use
veterinari
medicin
mani
year
vaccin
felin
leukaemia
viru
retroviru
sect
contain
extern
glycoprotein
subtyp
viru
immunolog
relev
compon
produc
purifi
escherichia
coli
cell
nonglycosyl
form
genet
engin
method
vaccin
consist
synthet
peptid
length
amino
acid
repres
addit
form
vaccin
current
test
case
individu
epitop
viral
protein
induc
product
neutral
antibodi
also
activ
cell
select
chemic
synthes
one
advantag
vaccin
devoid
nucleic
acid
produc
larg
quantiti
rel
littl
effort
anim
studi
protect
effect
synthet
peptid
vaccin
demonstr
infect
footandmouth
diseas
viru
sect
canin
parvoviru
sect
prerequisit
develop
vaccin
also
case
detail
knowledg
protein
region
elicit
virusneutr
immun
respons
howev
seem
rather
doubt
singl
epitop
abl
long
term
virus
high
genet
variabl
furthermor
singl
individu
differ
abil
immunolog
recognit
specif
protein
region
interrel
distinct
mhc
phenotyp
individu
vaccin
base
synthet
peptid
sever
differ
epitop
ought
combin
appli
suitabl
adjuv
vaccin
base
synthet
peptid
approv
yet
anoth
new
vaccin
type
administ
dna
nucleic
acid
contain
gene
viru
capabl
induc
protect
immun
respons
ie
usual
region
encod
surfac
compon
pathogen
clone
vector
system
togeth
promot
element
regul
express
inject
intramuscularli
purifi
dna
particularli
muscl
cell
dna
detect
long
period
episom
appar
degrad
slowli
correspond
gene
express
organ
appar
develop
humor
cellular
immun
respons
type
vaccin
test
predominantli
anim
system
anim
studi
protect
effect
vaccin
demonstr
varieti
differ
anim
pathogen
virus
paramyxoviru
parvoviru
herpesviru
howev
larg
amount
dna
number
booster
inject
necessari
faster
degrad
nucleic
acid
also
observ
howev
inher
possibl
integr
dna
sequenc
appli
vaccin
cellular
genom
result
endanger
vaccine
addit
problem
consid
discuss
harmless
dna
vaccin
virus
rna
genom
present
special
challeng
develop
vaccin
use
genet
engin
method
inasmuch
techniqu
target
introduct
mutat
express
foreign
gene
prokaryot
eukaryot
system
base
dna
initi
nucleic
acid
genet
inform
rna
virus
must
first
transcrib
doublestrand
dna
becom
access
genet
engin
manipul
target
mutat
select
introduc
nucleic
acid
sequenc
dna
construct
eg
gener
attenu
vaccin
virus
case
genom
rna
virus
previous
transcrib
dna
must
present
form
subsequ
allow
synthesi
infecti
virus
process
describ
method
revers
genet
attempt
exampl
construct
attenu
live
vaccin
respiratori
syncyti
viru
paramyxovirus
sect
virus
segment
rna
genom
influenza
virus
repres
particular
challeng
case
genet
inform
segment
viral
rna
genom
must
transcrib
dna
clone
appropri
eukaryot
express
vector
combin
synthesi
viral
protein
product
new
genom
segment
recombin
virus
subsequ
produc
cultiv
appropri
cell
cultur
system
attenu
viru
possibl
target
mutagenesi
futur
facilit
faster
adapt
new
vaccin
strain
new
influenza
virus
sect
case
also
attempt
develop
novel
vaccin
rapidli
use
prefabr
genom
librari
univers
vaccin
order
cover
new
influenza
viru
subtyp
pandem
dimens
marker
vaccin
great
import
veterinari
medicin
allow
distinct
vaccin
anim
fieldvirusinfect
anim
wildtyp
viru
use
simpl
serolog
method
chap
vaccin
also
refer
diva
vaccin
differenti
infect
vaccin
principl
differenti
made
neg
posit
marker
vaccin
first
case
vaccin
viru
lack
gene
respect
protein
vaccin
anim
develop
immunolog
reaction
respect
protein
distinct
fieldvirusinfect
anim
perform
determin
specif
antibodi
direct
protein
prerequisit
success
approach
miss
protein
exert
essenti
function
viral
replic
suffici
specif
antibodi
relev
protein
produc
infect
wildtyp
virus
veterinari
medicin
neg
marker
vaccin
administ
control
two
econom
import
herpesviru
infect
name
aujeszki
diseas
swine
infecti
bovin
rhinotrach
cattl
tabl
sect
posit
marker
vaccin
vaccin
virus
character
uniqu
marker
nucleic
acid
sequenc
case
vaccin
failur
ie
case
infect
establish
spite
vaccin
posit
marker
vaccin
facilit
easi
identif
vaccin
virus
